Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states
Kelly Bruno1,2,3, Sarah A Woller1, Yury I Miller4
1Department of Anesthesiology and Pain Medicine, University of California San Diego Health Sciences, La Jolla, CA, United States.
Abstract:
Toll-like receptors (TLRs) are a family of pattern recognition receptors that initiate signaling in innate and adaptive immune pathways. The highly conserved family of transmembrane proteins comprises an extracellular domain that recognizes exogenous and endogenous danger molecules and an ectodomain that activates downstream pathways in response. Recent studies suggest that continuous activation or dysregulation of TLR signaling may contribute to chronic disease states. The receptor is located not only on inflammatory cells (meningeal and peripheral macrophages) but on neuraxial glia (microglia and astrocytes), Schwann cells, fibroblasts, dorsal root ganglia, and dorsal horn neurons. Procedures blocking TLR functionality have shown pronounced effects on pain behavior otherwise observed in models of chronic inflammation and nerve injury. This review addresses the role of TLR4 as an emerging therapeutic target for the evolution of persistent pain and its role in noncanonical signaling, mediating anomalous pro-algesic actions of opiates. Accordingly, molecules targeting inhibition of this receptor have promise as disease-modifying and opioid-sparing alternatives for persistent pain states.
Insights
Toll-like receptor 4 (TLR4) plays a key role in persistent pain. Inhibiting TLR4 shows promise for treating chronic pain and reducing opioid reliance.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Toll-like receptors (TLRs) are pattern recognition receptors crucial for innate and adaptive immunity.
- Dysregulated TLR signaling is implicated in chronic disease states.
- TLRs are expressed on various immune and neural cells, including microglia, astrocytes, and neurons.
Purpose of the Study:
- To review the role of TLR4 in persistent pain.
- To explore TLR4's involvement in noncanonical signaling and opioid effects.
- To highlight TLR4 as a therapeutic target for chronic pain.
Main Methods:
- Literature review of studies on TLRs, pain pathways, and therapeutic interventions.
- Analysis of TLR4 expression and function in relevant cell types.
- Examination of preclinical data on TLR4 inhibition in pain models.
Main Results:
- TLR4 signaling contributes to pain behavior in chronic inflammation and nerve injury models.
- TLR4 mediates pro-algesic actions of opiates through noncanonical pathways.
- Blocking TLR4 function significantly impacts pain behaviors.
Conclusions:
- TLR4 is a promising therapeutic target for persistent pain.
- Targeting TLR4 may offer disease-modifying and opioid-sparing benefits.
- Inhibition of TLR4 presents a novel strategy for managing chronic pain states.
More Related Videos
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Emerging Adulthood
Internal Receptors
Pain